Stijn van Dongen
- Molecular Biology top 0.5%
- Cancer Research top 0.1%
- Plant Science top 2%
- Immunology top 2%
- Genetics top 5%
- Co-authors
- Anton J. EnrightHarpreet K. SainiSam Griffiths‐JonesCei Abreu‐GoodgerRussell GrocockYuichiro MishimaKunio InoueAntonio J. Giráldez
- Topics
- MicroRNA in disease regulation (16 papers)Cancer-related molecular mechanisms research (12 papers)Circular RNAs in diseases (5 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Stijn van Dongen
35 papers receiving 9.4k citations
Hit Papers
Peers
Comparison fields: 5 of 177
- Molecular Biology 6.9k
- Cancer Research 5.2k
- Plant Science 995
- Immunology 953
- Genetics 568
Countries citing papers authored by Stijn van Dongen
This map shows the geographic impact of Stijn van Dongen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stijn van Dongen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stijn van Dongen more than expected).
Fields of papers citing papers by Stijn van Dongen
This network shows the impact of papers produced by Stijn van Dongen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stijn van Dongen. The network helps show where Stijn van Dongen may publish in the future.
Co-authorship network of co-authors of Stijn van Dongen
This figure shows the co-authorship network connecting the top 25 collaborators of Stijn van Dongen. A scholar is included among the top collaborators of Stijn van Dongen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stijn van Dongen. Stijn van Dongen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 48 | |
| 3 | 35 | |
| 4 | 46 | |
| 5 | 23 | |
| 6 | 44 | |
| 7 | 33 | |
| 8 | 66 | |
| 9 | 286 | |
| 10 | 15 | |
| 11 | 282 | |
| 12 | 17 | |
| 13 | 217 | |
| 14 | 20 | |
| 15 | 55 | |
| 16 | 241 | |
| 17 | Requirement of bic/microRNA-155 for Normal Immune Functionbreakdown → | 1561 |
| 18 | 176 | |
| 19 | Zebrafish MiR-430 Promotes Deadenylation and Clearance of Maternal mRNAsbreakdown → | 1238 |
| 20 | 9 |
About Stijn van Dongen
Stijn van Dongen is a scholar working on Cancer Research, Aging and Sensory Systems, having authored 35 papers that have together received 9.6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (16 papers), Cancer-related molecular mechanisms research (12 papers) and Circular RNAs in diseases (5 papers). The work is most often cited by research in Cancer Research (5.2k citations), Molecular Biology (6.9k citations) and Aging (105 citations). Stijn van Dongen has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Anton J. Enright, Harpreet K. Saini, Sam Griffiths‐Jones, Cei Abreu‐Goodger, Russell Grocock, Yuichiro Mishima, Kunio Inoue, Antonio J. Giráldez, Alexander F. Schier and Jason Rihel. Their work appears in journals such as Science, Nucleic Acids Research and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.